Circulating ATLL cells posttreatment resemble tumor-infiltrating Tregs. RNAseq was used to profile gene-expression changes caused by nivolumab treatment. The color bar indicates the fold change (after/before) for each gene. Selected genes represent genes associated with Tregs and lymphocyte checkpoint pathways that increase or decrease more than twofold after treatment with nivolumab.